Market cap
$224 Mln
Revenue (TTM)
$409 Mln
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 8.91 | -9.15 | -3.92 | 1.83 | 0.92 |
| EBIT | -474.93 | -273.70 | 4.88 | 7.16 | 1.37 |
| Net Profit | -246.14 | -491.37 | -23.02 | 7.74 | -1.96 |
| EPS | -243.45 | -470.32 | -18.67 | 6.01 | 1.89 |
| Book Value | -- | -- | -24.00 | -10.90 | -2.38 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -17.62 | -19.78 | -34.35 | -21.13 | 2.63 |
| Net Margin
| 0.73 | -18.67 | -- | -- | 0.73 |
| Return on equity
| -24.07 | -27.53 | -43.28 | -29.89 | 0.96 |
| Return on Capital
| -13.32 | -15.41 | -22.75 | -17.80 | 0.61 |
| Return on Assets
| -11.15 | -13.18 | -19.07 | -14.90 | 0.51 |
| Debt to Equity (x)
| -- | -- | 1.09 | 0.76 | 0.61 |
Profitability
ROCE
-22.75
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-22.75
|
-17.80
|
0.61
|
-22.15
|
-14.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-43.28
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-43.28
|
-29.89
|
0.96
|
-37.96
|
-27.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-19.07
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-19.07
|
-14.90
|
0.51
|
-19.26
|
-13.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-34.35
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-34.35
|
-21.13
|
2.63
|
-28.71
|
-17.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-27.77
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-27.77
|
-21.69
|
0.73
|
-33.96
|
-22.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.04
--
Year on year growth in net sales
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-0.04
|
0.05
|
0.05
|
0.07
|
-0.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-56.21
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-56.21
|
-939.99
|
109.63
|
-76.73
|
34.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-23.02
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-23.02
|
-3,172.74
|
102.28
|
-58.14
|
19.89
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-0.19
--
Year on year growth in earnings per share
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-0.19
|
-31.05
|
1.02
|
-0.56
|
0.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.09
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
1.09
|
0.76
|
0.61
|
0.55
|
0.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.16
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
0.16
|
0.02
|
0.02
|
0.02
|
0.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.62
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
4.62
|
6.37
|
7.11
|
6.46
|
3.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
3.62
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
3.62
|
4.94
|
5.85
|
5.32
|
2.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-5.22
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-5.22
|
-11.21
|
1.66
|
-5.62
|
-2.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
17.60
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
17.60
|
18.67
|
19.42
|
18.22
|
21.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.69
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
0.69
|
0.69
|
0.69
|
0.57
|
0.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
67.62
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
67.62
|
68.00
|
67.14
|
69.93
|
80.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
291.62
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
291.62
|
295.08
|
271.35
|
267.17
|
284.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
61.73
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
61.73
|
66.73
|
82.67
|
83.27
|
59.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
297.52
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
297.52
|
296.35
|
255.82
|
253.82
|
305.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-1.23
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-1.23
|
-8.47
|
468.11
|
-21.58
|
-71.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.61
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
0.61
|
2.66
|
4.34
|
9.34
|
15.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.78
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Nevro (NVRO)
|
-0.78
|
-8.68
|
58.39
|
-25.78
|
-104.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|